Archive

In our practice, we usually see commercial contracts in which receivables arising from these contracts are not assignable and/or cannot be pledged. The rationale is that parties do not want to be faced with a creditor other than the party they have contracted with. The consequence of a restriction clause is that the relevant receivables cannot be used as collateral in a financing transaction or transferred in the…

Rutgers & Posch advises Zorg van de Zaak, the company health network in the Netherlands, in relation to its disposal of Naviva Kraamzorg, one of the largest maternity care providers in the Netherlands, to Morefield, a subsidiary of investment company Value 8. The transaction is subject to regulatory approvals. The team of Rutgers & Posch consisted of Matthijs van den Broek, Inge de Laat, Veerle Cordemeijer, Hanna Steensma,…

Rutgers & Posch represented NASDAQ listed uniQure N.V. in respect of its $75 million fully underwritten public offering of new ordinary shares. uniQure is advancing a pipeline of proprietary gene therapies for the treatment of patients with Huntington’s disease, refractory temporal lobe epilepsy, ALS, Fabry disease, and other severe diseases. Bas Visée and Jamie Pellegrom advised uniQure. Rutgers & Posch teamed up with US firm Morgan Lewis. For…

Rutgers & Posch advises top clinical hospital Medisch Spectrum Twente (MST) on its collaboration with Eyescan. MST and Eyescan have started a joint venture in the field of ophthalmology in the Twente region. With the collaboration, parties are better able to meet the increasing demand for eye care. MST is one of the largest non-academic hospitals in the Netherlands with locations in Enschede and Oldenzaal, and Eyescan is…

Rutgers & Posch advises Ridder, a Dutch global leader in horticulture automation solutions, providing advanced technology and connected smart solutions to growers in over 100 countries, in relation to its strategic partnership with Navus CEA Enterprises, a “spin off” of Navus Ventures, both investment companies belonging to the Lanvi group, as does Lely (Farming innovators). The team of Rutgers & Posch consisted of Matthijs van den Broek, Veerle…

Rutgers & Posch advises Hospital SJG Weert on its collaboration with academic hospital Maastricht UMC+ (MUMC+). As part of the collaboration SJG Weert will be converted into a limited liability company whereby MUMC+ acquires all shares. SJG Weert remains an independent hospital with its own management board and an independent supervisory board. The purpose of the collaboration is to ensure the accessibility of care in the province of…